Germany Blood And Blood Forming Organs Medicine Sales is set to reach $5,790 Million by 2026 from $4,870 Million, will be up 9.2% per year. Since 2017, the market rose 6.1% year on year attaining $27,250 Million. Germany, Italy and South Korea respectively ranked numbers 2, 3 and 4 in this ranking.
How does Germany perform in Blood Disease?
Forecast: Blood and Blood Forming Organs Medicine Sales in Germany
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Germany
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Germany
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Germany
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Germany
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Infant Mortality Rate Due to Haemorrhagic and Haematological Disorders of Fetus and Newborn, by Sex in Germany
- Units (Deaths) Per Thousand Live Births
- 2024 to 2028
- ReportLinker Research
Forecast: Prevalence of Anemia in Germany
- Percent of Children Under 5
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Anaemias Cases in Germany
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research